M icroRNAs (miRNAs) are a class of endogenous, noncoding single-stranded ~22-nucleotide RNAs, many of which are evolutionarily conserved. Based on sequence complementarities, miRNAs target mRNAs and regulate posttranscriptional gene expression 1, 2 . With a high degree of spatial and temporal specificity, miRNAs regulate neurogenesis, synaptic plasticity, and circadian rhythm [3] [4] [5] [6] . Thus, miRNAs could orchestrate neuronal development and plasticity by modulating complex gene networks. The perturbation of miRNA expression could potentially contribute to the etiology of human diseases, including neuropsychiatric disorders.
Previous meta-analyses combining genome-wide association studies from 17 separate studies identified a locus on chromosome 1p21.3 to be highly associated with schizophrenia [7] [8] [9] [10] . MIR137 resides in this locus and encodes miR-137. Notably, four other loci achieving genome-wide significance in the same studies contain the genes predicted to be regulated by miR-137. Moreover, MIR137 is also associated with autism spectrum disorders (ASD); in largescale copy-number variation analyses of people with ASD, the riskpathogenic copy-number variants overlap with the loci containing MIR137 7, 10, 11 . Besides schizophrenia and ASD, MIR137 has also been linked to bipolar disorder 12 . These findings together suggest that miR-137 contributes to the pathogenesis of neuropsychiatric disorders. However, whether the dysregulation of miR-137 leads directly to the phenotypes associated with neuropsychiatric disorders remains to be determined.
Previously published works have demonstrated the critical roles of miR-137 in neurogenesis, neuronal maturation, and dendritic morphogenesis during neurodevelopment 13, 14 . More recently, using induced human neurons, overexpression of miR-137 has been shown to impair synaptic plasticity and learning and memory in the hippocampus 15 . The minor allele associated with schizophrenia can increase MIR137 expression, suggesting that miR-137 gain-offunction might be associated with this disease 8, 10, 12, 16 . However, little is known about the in vivo impact of the loss of miR-137, which is critical given that the microdeletions of MIR137 are linked to ASD in multiple reports 11, [17] [18] [19] [20] .
In this study we generated a miR-137 conditional allele to investigate the impact of miR-137 loss of function in vivo. We show that miR-137 is critical for postnatal mouse development. Partial loss of miR-137 leads to the dysregulation of synaptic plasticity, altered repetitive or stereotyped behaviors, and impaired sociability and social novelty preference. Combining large-scale proteomic analyses with gene expression profiling identified the mRNAs that miR-137 post-transcriptionally regulates. By overlapping with known genes linked to neuropsychiatric disorders, we found a significant
Partial loss of psychiatric risk gene Mir137 in mice causes repetitive behavior and impairs sociability and learning via increased Pde10a
Ying 
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NATuRe NeuROsCIeNCe enrichment of ASD-associated genes among miR-137 targets (P = 0.0009). One of the miR-137 mRNA targets, Pde10a, was significantly upregulated in vivo upon partial loss of miR-137 (P = 0.0172). A specific Pde10a inhibitor, papaverine, can ameliorate the deficits associated with the partial loss of miR-137. Additional short hairpin RNA (shRNA)-mediated knockdown of Pde10a resulted in similar rescue effects, supporting the hypothesis that the increased expression of Pde10a was responsible for the observed abnormalities. These results together highlight the critical roles of MIR137 in postnatal neurodevelopment and suggest that the dysregulation of miR-137 contributes to neuropsychiatric disorders in humans.
results
Loss of miR-137 in germline and nervous system leads to postnatal lethality. To generate miR-137 knockout mice, we designed a targeting vector to disrupt the Mir137 gene via homologous recombination in mouse embryonic stem cells, where two loxP sites were inserted upstream (~2 kb) and downstream (~0.6 kb) of the A targeting vector was designed to disrupt the Mir137 gene via homologous recombination in mouse embryonic stem cells, where two loxP sites were inserted upstream (~2 kb) and downstream (~0.6 kb) of the Mir137 gene (this image was modified from the UCSC Genome Browser). b, Schematic of the crosses to generate Mir137-knockout mice. Green arrows indicate the primer sets designed for PCR genotyping. P_F, forward primer; P_WT-R, reverse primer to detect wild-type band; P_KO-R, reverse primer to detect knockout band. By crossing with either Zp3-Cre or Nestin-Cre mouse lines, we specifically deleted Mir137 in the germline or central and peripheral nervous system and generated heterozygous gKO (Mir137 +/-) and cKO (Mir137 loxP/+ ;Nestin-Cre) mice. c-d, Gross appearance of miR-137 gKO mice. (c) Representative wild-type (Mir137 +/+ ), heterozygous (Mir137 +/-) and homozygous (Mir137 -/-) of Mir137-knockout mice and brain tissues. (d) At P16, the body and brain weights of Mir137 -/mice were much smaller than Mir137 +/+ and Mir137 +/mice (n = 5 mice per group; data represent means ± s.e.m.; body: F 2,12 = 1,123, P < 0.0001; brain: F 2,12 = 67.05, ****P < 0.0001; one-way ANOVA with Bonferroni post hoc test; nonsignificant 
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Mir137 gene, and derived mice carrying the loxP-flanked allele of miR-137 ( Fig. 1a ). By crossing with either Zp3-Cre or Nestin-Cre line mice, we deleted Mir137 in the germline or nervous system and generated heterozygous miR-137 global knockout (gKO) and conditional knockout (cKO) mice ( Fig. 1b ). miR-137 wild-type (Mir137 +/+ or Mir137 loxP/+ ), heterozygous (Mir137 +/or Mir137 loxP/+ ;Nestin-Cre), and homozygous (Mir137 -/or Mir137 loxP/loxP ;Nestin-Cre) mice were used in the following analyses. We found significantly reduced levels of mature miR-137 in the brain upon the loss of Mir137 (P < 0.0001; Supplementary Fig. 1a,b and Supplementary Table 1 ). mir-137 in the nervous system leads to synaptic overgrowth and impaired dendritic growth in vivo. a, Immunohistochemistry (IHC) staining of PSD-95 and synaptophysin in miR-137 cKO mice hippocampal tissues. PSD-95 and synaptophysin IHC staining were carried out on 40-μ m thick floating sections containing hippocampal tissue from four pairs of littermate cKO mice, that is, Mir137 loxP/+ , Mir137 loxP/+ ;Nestin-Cre, and Mir137 loxP/loxP ; Nestin-Cre mice, at P18 (n = 4 mice per group). Relative fluorescence intensities of PSD-95 (F 2,9 = 9.494, P = 0.0061) and synaptophysin (F 2,9 = 12.73, P = 0.0024) were elevated upon the loss of miR-137 in the hippocampus (data represent means ± s.e.m.; one-way ANOVA with Bonferroni post hoc test; n.s., nonsignificant; *P < 0.05; **P < 0.01). Image analyses and quantification were performed using ImageJ software. b-e, Golgi staining reveals dendritic growth in the hippocampal CA1 region in Mir137 loxP/+ and Mir137 loxP/+ ;Nestin-Cre mice (n = 13 slices from 4 mice per group). (b) The spine densities of basal (t = 3.895, P = 0.0007) and apical (t = 5.406, P < 0.0001) spines were significantly increased in Mir137 loxP/+ ;Nestin-Cre mice compared to in littermate controls (data represent means ± s.e.m.; unpaired two-tailed t test; ***P < 0.001; ****P < 0.0001). (c) Sholl analysis showing that, compared with neurons in Mir137 loxP/+ mice, CA1 pyramidal neurons in Mir137 loxP/+ ;Nestin-Cre mice exhibited increased dendritic complexity (data represent means ± s.e.m.; basal spines: t 80 = 3.952, P = 0.0016; t 90 = 4.534, P = 0.0001; t 110 = 3.047, P = 0.0437; apical spines: t 70 = 3.210, P = 0.0388; t 110 = 4.105, P = 0.0013; t 120 = 4.004, P = 0.0019; t 130 = 5.242, P < 0.0001; t 140 = 3.493, P = 0.0143; two-way ANOVA with Bonferroni post hoc test; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; distance points with P < 0.05 not marked in the figure). Partial loss of miR-137 significantly increased (d) dendritic length (t basal = 3.275, P = 0.0023; t apical = 3.905, P = 0.0003; t total = 4.422, P < 0.0001) and (e) dendritic nodes (t basal = 2.118, P = 0.0377; t apical = 2.675, P = 0.0092) in Mir137 loxP/+ ;Nestin-Cre neurons (data represent means ± s.e.m.; unpaired two-tailed t test; *P < 0.05; **P < 0.01; ***P < 0.001). Mir137 loxP/+ ;Nestin-Cre (n = 10 mice) mice showed improved latency to locate the platform, but Mir137 loxP/+ ;Nestin-Cre mice exhibited a significant delay to diminish the latency to locate the platform (data represent means ± s.e.m.; t day1 = 0.026, P > 0.9999; t day2 = 2.565, P = 0.0501; t day3 = 3.766, P = 0.0014; t day4 = 6.761, P < 0.0001; two-way ANOVA with Bonferroni post hoc test; **P < 0.01; ****P < 0.0001). (b) In probe trials on Day 5, there was no significant difference in swimming speeds between the two groups of mice (t = 0.524, P = 0.6073). Compared to Mir137 loxP/+ , Mir137 loxP/+ ;Nestin-Cre mice exhibited (c) a significantly longer latency to locate the platform (t = 5.530, P < 0.0001), but (d) fewer target crossings (t = 3.213, P = 0.0051; data shown are means ± s.e.m.; unpaired two-tailed t test; **P < 0.01; ****P < 0.0001). e-h, miR-137 cKO mice were subject to the Barnes maze test. (e) During the training phase, in which 4 trials were conducted per day for 4 successive days, the Mir137 loxP/+ ;Nestin-Cre mice (n = 15 mice) failed to diminish the latency of first entrance to the hiding box, indicating that loss of miR-137 results in impaired spatial memory (data represent means ± s.e.m.; t day1 = 0.842, P > 0.9999; t day2 = 1.864, P = 0.2603; t day3 = 2.220, P = 0.1141; t day4 = 4.025, P = 0.0004; two-way ANOVA with Bonferroni post hoc test; ***P < 0.001). Probe trials on Day 5 demonstrated that Mir137 loxP/+ ;Nestin-Cre mice also had spatial memory deficits, as they (f) spent less time (t = 2.537, P = 0.0173) in the target quadrant and (g) visited the target hole less often (t = 3.978, P = 0.0005) than Mir137 loxP/+ mice (n = 14 mice). (h) We found no significant difference in distances traveled between the two groups (t = 1.713, P = 0.0981; data shown are means ± s.e.m.; unpaired two-tailed t test; n.s., nonsignificant; *P < 0.05; ***P < 0.001). i,j, Partial loss of miR-137 resulted in impaired LTP in 
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Deletion of Mir137 did not affect the expression of an adjacent gene, dihydropyrimidine dehydrogenase (Dpyd; Supplementary Fig. 1c ), but complete loss of miR-137 (gKO) resulted in postnatal lethality in Mir137 -/mice, which survived up to postnatal day (P) 21, while partial loss of miR-137 did not affect the survival rate of Mir137 +/mice ( Supplementary Fig. 1d ). Compared to Mir137 +/+ littermates, Mir137 +/mice showed few differences in body and brain weights, while body and brain weights were significantly decreased in Mir137 -/mice ( Fig. 1c,d ).
To examine whether the loss of miR-137 impaired embryonic and early postnatal development, we performed timed mating using heterozygous mice. We collected embryos at embryonic day 15.5 and found few morphological differences among Mir137 +/+ , Mir137 +/-, and Mir137 -/mice ( Supplementary Fig. 2a ). At the early postnatal stage (P0), Mir137 +/+ and Mir137 -/mice were similar in terms of size and weight ( Supplementary Fig. 2b ), but the differences were usually observed as early as P7 (data not shown), suggesting a postnatal effect of miR-137 loss-of-function. At P14 the major organs (heart, liver, lungs, and kidneys) of Mir137 -/mice were smaller than those of their Mir137 +/+ and Mir137 +/littermates ( Supplementary Fig. 2c ). Major organ sections stained with hematoxylin and eosin showed no apparent morphological differences ( Supplementary Fig. 2d ).
In miR-137 cKO mice, miR-137 was deleted specifically in the nervous system to more accurately reflect the neuronal phenotype; we found mature miR-137 expression in brain significantly reduced in Mir137 loxP/+ ;Nestin-Cre and Mir137 loxP/loxP ;Nestin-Cre mice compared to littermate controls ( Fig. 1e ). We also observed similar postnatal lethality in homozygous miR-137 cKO (Mir137 loxP/loxP ; Nestin-Cre) mice during postnatal development ( Fig. 1f ), strongly suggesting that the phenotypes in miR-137 gKO mice result from the loss of miR-137 in the nervous system. Therefore, we mainly focused on miR-137 cKO mice to understand the in vivo roles of miR-137 in the brain.
Loss of miR-137 results in the dysregulation of synaptic plasticity.
PSD-95 and synaptophysin immunohistochemistry staining was performed using hippocampal or cortical tissues from miR-137 cKO mice at P18 to determine whether the loss of miR-137 influenced synaptic growth in vivo. In both hippocampal and cortical tissues, the relative fluorescence intensities and protein levels of PSD-95 and synaptophysin increased in Mir137 loxP/+ ;Nestin-Cre and Mir137 loxP/loxP ; Nestin-Cre mice when compared to their Mir137 loxP/+ siblings, indicating synapse overgrowth upon loss of miR-137 ( Fig. 2a and Supplementary Fig. 3a -c). We also performed caspase-3 staining in brain sections of miR-137 cKO mice at different developmental stages (P0, P18, and P60), but did not see any substantial change in caspase-3 expression between Mir137 loxP/+ and Mir137 loxP/+ ;Nestin-Cre mice, indicating that partial loss of miR-137 had limited impact on neuronal viability and apoptosis ( Supplementary Fig. 3d ). To further examine the spine structure in vivo, we performed Golgi staining in Mir137 loxP/+ and Mir137 loxP/+ ;Nestin-Cre mice and analyzed their dendritic spines in the hippocampal CA1 region. The spine densities of basal and apical spines were significantly increased in Mir137 loxP/+ ;Nestin-Cre mice compared to in littermate controls, indicating that loss of miR-137 resulted in synaptic pruning deficits ( Fig. 2b) . Also, compared with the neurons of Mir137 loxP/+ mice, the neurons in Mir137 loxP/+ ;Nestin-Cre mice exhibited increased dendritic complexity and enhanced dendritic growth ( Fig. 2c-e ). Consistently, we also observed similar increases of PSD-95 and synaptophysin in miR-137 gKO mice ( Supplementary Fig. 4a,b ). These results together suggest that miR-137 plays essential roles in regulating synaptic plasticity.
Partial loss of miR-137 leads to the deficits in learning and memory. Given the link between miR-137 and neuropsychiatric disorders, we then determined whether the loss of miR-137 led to any behavioral abnormalities relevant to neuropsychiatric disorders. We subjected miR-137 cKO and gKO mice to a battery of behavioral tests. Due to the postnatal lethality of the complete loss of miR-137, we focused on 2-to 3-month-old wild-type and heterozygotic miR-137 cKO and gKO mice.
Previous reports indicate that overexpression of miR-137 in the dentate gyrus impairs hippocampus-dependent learning 15 . We therefore asked whether the loss of miR-137 would also alter learning and memory in our MiR137-knockout mice. First, we performed the Morris water maze test ( Fig. 3a-d ). During the training phase (4 trials per day for 4 successive days), although both Mir137 loxP/+ and Mir137 loxP/+ ;Nestin-Cre mice showed improved latency to the platform, Mir137 loxP/+ ;Nestin-Cre mice exhibited a significant delay in finding the platform (Fig. 3a ). There was no significant difference in swimming speeds between the two groups of mice ( Fig. 3b ). In the subsequent probe test phase, Mir137 loxP/+ ;Nestin-Cre mice exhibited significantly higher latency to targets and fewer target crossings ( Fig. 3c,d ). Consistently, we observed similar changes in miR-137 gKO mice ( Supplementary Fig. 5a-d ). To further assess the impaired spatial learning and memory deficit in miR-137 cKO and gKO mice, we performed the Barnes maze test. Mice received training in the Barnes maze for 4 consecutive days, consisting of 4 trials per day to find the hiding box. We found that both Mir137 loxP/+ ;Nestin-Cre and Mir137 +/mice failed to diminish the latency of the first entry to the hiding box ( Fig. 3e and Supplementary Fig. 5e ). Probe trials on Day 5 demonstrated that both Mir137 loxP/+ ;Nestin-Cre and Mir137 +/mice had spatial memory deficits, as they visited the target hole less often and spent less time in the target quadrant than Mir137 loxP/+ mice and Mir137 +/+ (Fig. 3f,g and Supplementary Fig. 5f ,g). Distances traveled were not significantly different between the two groups ( Fig. 3h and Supplementary Fig. 5h ).
With these observed hippocampus-dependent learning deficits, we further investigated the effect of miR-137 deficiency in neuronal plasticity. We examined long-term potentiation (LTP) in acute hippocampal slices prepared from Mir137 loxP/+ and Mir137 loxP/+ ;Nestin-Cre mice. Compared to Mir137 loxP/+ , LTP was attenuated in Mir137 loxP/+ ;Nestin-Cre mice (Fig. 3i ). The amplitude of LTP 55-60 min after induction was significantly attenuated in Mir137 loxP/+ ;Nestin-Cre mice compared with Mir137 loxP/+ mice ( Fig. 3j ). Also, we examined paired-pulse facilitation across interpulse intervals of 20, 50, 100, 200, and 400 ms. Compared to Mir137 loxP/+ mice, we found a significant reduction of the paired-pulse ratio in Mir137 loxP/+ ;Nestin-Cre mice at the 50-ms interval ( Fig. 3k ,l). These electrophysiological results indicate that miR-137 played vital roles in maintaining the normal synaptic plasticity. Together, these data suggest that the loss of miR-137 resulted in the deficits in learning and memory. Prior studies found that the overexpression of miR-137 could result in impaired learning and memory as well, indicating that miR-137-mediated regulation could be dosage-dependent.
Partial loss of miR-137 leads to altered repetitive behaviors, impaired sociability, and impaired social novelty preference.
Impaired social functioning is a characteristic phenotype associated with schizophrenia and ASD, and deficits in social memory are also characteristic of some forms of intellectual disability (ID) 21, 22 . Genomic deletion of MIR137 in patients is usually accompanied by ASD phenotypes; for example, of 12 individuals carrying a microdeletion in chromosome 1p21.3, containing MIR137, 11 are reported to have ASD, a 92% incidence [10] [11] [12] [13] . Therefore, we decided to examine the changes in social and repetitive behaviors, which are the core features of ASD. To assess repetitive and/or stereotyped behaviors, we recorded self-grooming bouts and performed the marbleburying test. We found that Mir137 loxP/+ ;Nestin-Cre mice exhibited significantly more and longer bouts of self-grooming ( Fig. 4a ) and buried more marbles than Mir137 loxP/+ littermates (Fig. 4b ). In
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the open field test, there was slight difference in the total distance moved during the 30-min period ( Fig. 4c ), suggesting similar locomotor activities between Mir137 loxP/+ and Mir137 loxP/+ ;Nestin-Cre mice. On the other hand, the Mir137 loxP/+ ;Nestin-Cre mice entered the center zone significantly fewer times than Mir137 loxP/+ mice ( Fig. 4c ), indicating elevated anxiety-like behavior. To characterize the social behavior of the Mir137 loxP/+ ;Nestin-Cre mice, we performed the social interaction test. We found that, compared to Mir137 loxP/+ littermates, Mir137 loxP/+ ;Nestin-Cre mice spent similar amounts of time exploring the arena, but excessively self-groomed when in contact with unfamiliar mice ( Fig. 4d and Supplementary  Fig. 6a ). These data together suggest that partial loss of miR-137 led to a specific social deficit and unusual repetitive behavior in Mir137 loxP/+ ;Nestin-Cre mice.
We next evaluated the sociability and social novelty of miR-137-knockout mice using the three-chamber test. In miR-137 cKO mice, both Mir137 loxP/+ and Mir137 loxP/+ ;Nestin-Cre mice showed no preference for either left chamber or right chamber during the habituation phase ( Fig. 4e and Supplementary Fig. 6b ), but Mir137 loxP/+ ;Nestin-Cre mice showed a limited social preference for a mouse over an object ( Fig. 4f ). Unlike Mir137 loxP/+ control mice, Mir137 loxP/+ ;Nestin-Cre mice demonstrated no preference for a strange mouse over a familiar mouse ( Fig. 4g ). We also confirmed these abnormal social behaviors in miR-137 gKO mice ( Supplementary Fig. 6c -e).
To further assess the impaired social behavior associated with the partial loss of miR-137, we then used another modified protocol of the social discrimination test to probe the mice for their social discrimination ability 23, 24 . We found that Mir137 +/and Mir137 loxP/+ ;Nestin-Cre mice had significantly fewer entries into the novel-mouse zone and spent significantly less time with the novel mouse compared to their littermate controls (Fig. 4h ,i and Supplementary Fig. 6f ,g).
Alterations of the excitation-inhibition ratio are associated with, and thought to cause, a wide range of neurological and mental disorders, including autism and schizophrenia [25] [26] [27] . In support of this, we found that upon partial loss of miR-137, the excitation-inhibition ratio significantly decreased in Mir137 loxP/+ ;Nestin-Cre mice compared to their Mir137 loxP/+ littermates ( Fig. 4j,k) . Other reports indicate that overexpression of miR-137 has minimal impact on social behaviors; 15 in contrast, our observations showed that the partial loss of miR-137 (both in germline and CNS) led to abnormal sociability, social novelty, and recognition in mice, supporting the idea that partial loss of miR-137 leads to the phenotypes associated with ASD.
Genome-wide identification of in vivo mRNA targets of miR-137.
Given the role of miRNAs in post-transcriptional gene regulation, we conducted tandem mass tagging (TMT)-based quantitative proteomics analysis using total protein from Mir137 +/+ , Mir137 +/-, and Mir137 -/-(age P12, two biological replicates from two littermates) brain cortical tissues ( Fig. 5a ). Replicates showed consistent TMT protein quantification results (Fig. 5b,c and Supplementary Fig. 7a ), and the relative abundance of selective proteins derived from the TMT-based MS quantification was further validated by western blotting ( Supplementary Fig. 7b ).
Using a widely used algorithm, Sylamer 28 , we checked the correlation between miRNA seed match enrichment in 3′ untranslated regions (UTRs) and protein log 2 fold changes ( Supplementary  Fig. 8a ). We found that upregulated proteins in Mir137 -/cortexes were specifically and substantially enriched for miR-137 binding sites (the top two enriched 7-nt sequences are predicted to be targeted by miR-137). When comparing Mir137 -/versus Mir137 +/+ , Mir137 +/versus Mir137 +/+ , and Mir137 -/versus Mir137 +/-, we identified differentially expressed (DE) genes encoding 417, 94, and 76 proteins, respectively (Supplementary Table 2 ). Gene ontology 
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NATuRe NeuROsCIeNCe analyses showed that the upregulated proteins (Mir137 -/versus Mir137 +/+ ) were substantially involved in DNA replication, nervous system development, and chromatin remodeling, while the downregulated proteins were enriched in genes that play important roles in peptidase activity regulation, acute-phase response, and regulation of neurotransmitter secretion ( Fig. 5d, Supplementary Fig. 8b , and Supplementary Table 2 ). Interactome analysis using the selected DE genes revealed a complex gene-regulatory network, suggesting that these DE genes might be associated with each other and result in dysfunction upon loss of miR-137 ( Fig. 5e ). Notably, several substantially downregulated genes encode proteins involved in ion transport and complement system regulation, which are reported to play essential roles in autism and schizophrenia [29] [30] [31] [32] . These data together suggest that the loss of miR-137 led to dysregulation of the genes involved in selective biological processes. These genes could be coregulated by miR-137 to influence postnatal neurodevelopment.
To identify the direct mRNA targets of miR-137, we overlapped the predicted miR-137 targets with those DE genes and identified 41 upregulated and 9 downregulated miR-137 predicted targets ( Fig. 5f ). We found that those upregulated DE genes were significantly associated with miR-137 predicted targets (Pearson's chi-squared test, P < 0.0001). Among the 41 upregulated miR-137 predicted targets, the mRNA levels of 37 genes (90%) as determined by RNA-seq ( Supplementary Table 3 ) changed little, suggesting that miR-137 regulated its direct targets post-transcriptionally.
We then explored whether miR-137 targets the known candidate genes of neuropsychiatric disorders. To do this, we overlapped the DE genes with ASD, schizophrenia, and ID candidate genes (Supplementary Fig. 9 and Supplementary Table 4 ). Notably, we found that the upregulated ASD candidate genes were significantly associated with miR-137 predicted targets (P = 0.0009), suggesting that miR-137 may play essential roles in ASD by Number of bouts ** S t r a n g e r 2 S t r a n g e r 1 S t r a n g e r 2 S t r a n g e r 1 Supplementary Fig. 8b . e, Interactome of DE genes upon loss of miR-137. The predicted protein-protein interaction network, generated with represented upregulated genes (blue circle) and downregulated genes (red circle), indicates the impact of miR-137 loss-of-function in various biological processes. Colored dots indicate DE genes in proteomics analysis. f, The overlap between miR-137 predicted targets and upregulated proteins. By overlapping with miR-137 predicted targets (1,140 transcripts with conserved sites), we found that miR-137 predicted targets significantly overlapped with upregulated DE genes (DE up ; 41 of 150), but not downregulated genes (DE down ; P values calculated by Pearson's chi-squared test). g, miR-137-mediated regulation in ASD candidate genes interactome. A predicted ASD-gene network exploring brain-specific interactions between ASD candidate genes was generated, including 15 upregulated and 16 downregulated DE proteins. Upregulated miR-137 predicted targets might potentially influence an adjacent ASD candidate gene's expression in mRNA and protein levels, for example, substantially downregulated GRIA3 and GABRB1 were previously reported as associated with ASD. Dots marked with bold lines indicate ASD candidate genes targeted by miR-137, as shown in Supplementary Fig. 9 .
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directly regulating the genes involved in ASD. Given the potential impact of miR-137 in ASD, we generated a predicted ASD-gene network to explore brain-specific interactions between ASD candidate genes, including the 15 upregulated and 16 downregulated DE genes ( Fig. 5g and Supplementary Fig. 9 ). In the predicted network, we found that upregulated miR-137-predicted targets potentially influenced the adjacent ASD candidate gene expression in protein levels. For example, downregulated GRIA3 (glutamate receptor subunit 3) and GABRB1 (gamma-aminobutyric acid receptor subunit beta-1) have been reported in association with ASD 33, 34 , and our results also showed substantially downregulation of GRIA3 and GABRB1 in Mir137 -/mice brain, which may partially explain the altered repetitive and social behaviors in mice upon loss of miR-137. Supplementary Fig. 15 .
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By overlapping with previously reported PSD and PSD-95 core complex proteins 35 , we found that a significant fraction of PSD and PSD-95 core complex genes were downregulated in Mir137 -/mice (P < 0.00001; Supplementary Fig. 10a ). Many of these downregulated PSD and PSD-95 core complex proteins are associated with ASD and schizophrenia ( Supplementary Fig. 10b ). Also, we found that a sizeable number of PSD and PSD-95 core complex genes could potentially be bound by miR-137 ( Supplementary Fig. 10c ). These results together suggest that the loss of miR-137 leads to the dysregulation of PSD and PSD-95 core complex proteins. miR-137 regulates its mRNA targets post-transcriptionally. To investigate miR-137-mediated mRNA regulation, we focused on the five most-upregulated miR-137 targets, Fam3c (family with sequence similarity 3, member C), Pde10a, Epha7 (ephrin type-A receptor 7), Foxp1 (forkhead box protein P1), and Shroom2 (shroom family member 2), as well as five miR-137 targets associated with neurological functions and disorders, Ptpn2 (protein tyrosine phosphatase, nonreceptor type 2), Satb2 (special AT-rich sequencebinding protein 2), Trim67 (tripartite motif containing 67), Cttnbp2nl (cortactin binding protein 2 N-terminal-like), and Tsn (translin; Supplementary Fig. 11a ). Using a dual luciferase reporter assay with the 3′ UTR of these genes, we found that eight of the ten miR-137 predicted targets could be regulated by miR-137 in vitro (Fig. 6a) . The decreased luciferase level was regulated by the overexpressed miR-137 rather than by the altered luciferase mRNA level ( Supplementary Fig. 11b and Supplementary Table 1 ). To identify critical genes regulated by miR-137, we examined the protein levels of the most-changed targets identified by the dual luciferase assay (that is, Ptpn2, Pde10a, and Stab2), and found a significant increase in Pde10a (P = 0.0135; Supplementary  Fig. 11c ), suggesting that the expression of Pde10a is sensitive to miR-137 expression.
To further confirm that miR-137 regulates the expression of Pde10a through the predicted binding site in the 3′ UTR of Pde10a, we mutated the Pde10a 3′ UTR by deleting the miR-137 target site (Pde10a-3′ UTR ΔMir137 ; Fig. 6b ). We found that miR-137 overexpression led to significant gene downregulation in the presence of original psi-CHECK2-Pde10a-3′ UTR but had a limited effect with psi-CHECK2-Pde10a-3′ UTR ΔMir137 , validating that Pde10a is a specific target of miR-137 ( Fig. 6c ). We also assessed whether the Pde10a 3′ UTR is, in fact, a target of endogenous miR-137. To do so, we used mouse Neuro-2a cells, which contain high miR-137 expression levels ( Supplementary Fig. 12a ), to perform miR-137 loss-of-function studies. We found that endogenous miR-137 could significantly suppress the gene expression in the presence of original psi-CHECK2-Pde10a-3′ UTR, but not with psi-CHECK2-Pde10a-3′ UTR ΔMir137 (P = 0.0012; Supplementary Fig. 12b ). Also, Pde10a 3′ UTR-dependent expression of a luciferase-reporter gene was increased with miR-137 inhibition, suggesting that Pde10a is a specific target of endogenous miR-137.
Previous studies show that Pde10a is enriched in brain and degrades cAMP (cyclic adenosine monophosphate) and cGMP (cyclic guanosine monophosphate), two critical signaling molecules that act as 'second messengers' to trigger physiological changes 36 and that are linked to psychiatric disorders 37 . We found that the increased Pde10a in Mir137 +/mice was associated with reduced phosphorylation of cAMP-dependent protein kinase (PKA), which Supplementary Fig. 15 .
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Inhibition of Pde10a ameliorates the abnormalities associated
with the partial loss of miR-137. Inhibition of Pde10a has been shown to ameliorate both dopaminergic and glutamatergic dysfunction, which made it an attractive possible therapeutic 38 . Given the substantial increase of Pde10a protein upon the partial loss of miR-137, we thus reasoned that a Pde10a inhibitor could potentially be used to inhibit the increase of Pde10a activity and might ameliorate the impaired behaviors associated with the partial loss of miR-137. To test this, we applied a widely used Pde10a-specific inhibitor, papaverine 38 , in the behavioral assays discussed above. We found that, to a certain extent, papaverine could rescue the impaired spatial memory in the Morris water maze and Barnes maze test ( Fig. 7a and Supplementary Fig. 13a ). In the two repetitive-behavior assays, S t r a n g e r 2 S t r a n g e r 1 S t r a n g e r 2 S t r a n g e r 1 S t r a n g e r 2 S t r a n g e r 1 S t r a n g e r 2 S t r a n g e r 1 S tr a n g e r 2 S tr a n g e r 1 S tr a n g e r 2 S tr a n g e r 1 S tr a n g e r 2 S tr a n g e r 1 S tr a n g e r 2 S tr a n g e r 1 
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we found that in Mir137 loxP/+ ;Nestin-Cre mice, papaverine treatment resulted in significantly less time spent self-grooming ( Fig. 7b ) and fewer marbles buried (Fig. 7c ), closer to the behavior observed in Mir137 loxP/+ mice. We found that papaverine rescued the impaired social behaviors associated with the partial loss of miR-137 ( Fig. 7d and Supplementary Fig. 13b ). With papaverine treatment, although Mir137 loxP/+ and Mir137 loxP/+ ;Nestin-Cre mice showed no significant difference in preference for entering the left or right chambers during the habituation phase, Mir137 loxP/+ ;Nestin-Cre mice exhibited significantly more interaction time with introduced and novel mice ( Fig. 7d and Supplementary Fig. 13b) . In the open field test, papaverine did not change the locomotor activity and number of entries in the center zone ( Supplementary Fig. 13c ) Papaverine could also rescue the impaired LTP in Mir137 loxP/+ ;Nestin-Cre mice (Fig. 7e ) and lead to a significant increase in paired-pulse ratios at the 50-ms interpulse interval in Mir137 loxP/+ ;Nestin-Cre mice (Fig. 7f ). Consistent with our observations in gKO mice, we also found that partial loss of miR-137 in Mir137 loxP/+ ;Nestin-Cre mice resulted in a significant increase in Pde10a (compared to Actin), which is associated with reduced phosphorylation of PKA without changing total PKA levels ( Fig. 7g ). Papaverine reduced phosphorylated PKA in Mir137 loxP/+ ;Nestin-Cre mice to its normal level in Mir137 loxP/+ mice (Fig. 7g ).
To examine whether papaverine could rescue the impaired nonbehavioral phenotype in vitro, we directly treated the primary hippocampal neurons isolated from P0 littermates of Mir137 loxP/+ and Mir137 loxP/+ ;Nestin-Cre mice treated with papaverine. We found that papaverine could substantially reduce the dendritic complexity, dendritic length, and numbers of nodes of Mir137 loxP/+ ;Nestin-Cre neurons ( Supplementary Fig. 13d-g) . These data together suggest that Pde10a is a key mRNA target of miR-137 and could potentially serve as a therapeutic target for the phenotypes associated with the loss of MIR137.
Knockdown of Pde10a rescues the deficits associated with the partial loss of miR-137. To strengthen the link between miR-137 and Pde10a, we generated lentiviruses encoding shRNA targeting Pde10a (sh-Pde10a), injected this lenti-sh-Pde10a in adult Mir137 loxP/+ and Mir137 loxP/+ ;Nestin-Cre mice, and assessed the impact of Pde10a-knockdown on the impaired phenotypes associated with the partial loss of miR-137 ( Fig. 8a,b and Supplementary Fig. 14a ).
In the Morris water maze test, the mean escape latency for the trained mice decreased over the course of the 5 learning days in all groups, and sh-Pde10a resulted in improved times for Mir137 loxP/+ ;Nestin-Cre mice to find the platform. In the probe trials, although sh-Pde10a did not change swimming speeds, it significantly improved the impaired latency to the platform and increased the number of target crossings in Mir137 loxP/+ ;Nestin-Cre mice (Fig. 8c ). In the three-chamber test, we found that Pde10aknockdown significantly improved the impaired sociability and social novelty in Mir137 loxP/+ ;Nestin-CreP = 0.1705; mice, without influencing their choice of the left or right chamber during the habituation phase (Fig. 8d ). In the self-grooming test, although not statistically significant (P = 0.1705), sh-Pde10a resulted in less time spent grooming in Mir137 loxP/+ ;Nestin-Cre mice ( Supplementary  Fig. 14b ). In the marble-burying test, sh-Pde10a ameliorated the impaired repetitive behaviors in Mir137 loxP/+ ;Nestin-Cre mice to the same level of Mir137 loxP/+ mice ( Supplementary Fig. 14c) . In the open field test, sh-Pde10a did not change the moving distance among the groups, but substantially ameliorated the anxiety-like behavior in Mir137 loxP/+ ;Nestin-Cre mice ( Supplementary Fig. 14d ).
Our earlier data indeed showed that papaverine resulted in the impaired dendritic growth of both Mir137 loxP/+ and Mir137 loxP/+ ;Nestin-Cre neurons, which may have occurred due to the toxicity of the papaverine solution ( Supplementary Fig. 13e-g) .
To confirm that Pde10a plays a role in dendritic growth, we infected primary cultured Mir137 loxP/+ and Mir137 loxP/+ ;Nestin-Cre neurons with sh-Pde10a lentivirus (Fig. 8e ). We found that knockdown of Pde10a rescued the impaired dendritic complexity and growth in Mir137 loxP/+ ;Nestin-Cre neurons, but not in Mir137 loxP/+ neurons ( Fig. 8f-h) . Also, we observed that knockdown of Pde10a could ameliorate the increased spine numbers of PSD-95 and synaptophysin in Mir137 loxP/+ ;Nestin-Cre neurons to a level similar to that in in Mir137 loxP/+ neurons ( Supplementary Fig. 14e ). Together, these data provide direct evidence that increased expression of Pde10a is responsible for the observed abnormalities.
Discussion
Genome-wide association studies have identified multiple loci that are likely involved in neuropsychiatric disorders, including schizophrenia, ASD, bipolar disorder, and depression 7, 10, 11, 39, 40 . Among them, MIR137 is associated with schizophrenia and ASD. In five independent studies, 11 of 12 individuals carrying a microdeletion in chromosome 1p21.3 were reported to have ASD and all had ID 11, [17] [18] [19] [20] . The minimal overlapping region of their deletions on chromosome 1p21.3 only includes the MIR137 gene, indicating that miR-137 mediates the core clinical features of ASD in patients carrying 1p21.3 deletion. Furthermore, gene expression analyses found that overexpression of MIR137 could be associated with schizophrenia 15 , while loss of MIR137 is likely associated with ASD 11 . Here we present the first characterization of Mir137-knockout mice at the molecular, cellular, electrophysiological, and behavioral levels. Our results suggest that miR-137 plays important roles in postnatal neurodevelopment and we provide direct evidence to support that the loss of miR-137 potentially causes ASD.
We observed that loss of miR-137 substantially influenced the expression of many known ASD genes. In particular, genes upregulated in ASD were significantly enriched with miR-137 predicted targets, such as Foxp1, Nfia, Satb2, and Tsn. For these genes, we only observed changes at the protein level, not at the RNA level. Given the critical roles of these genes in neurodevelopment, our results suggest important roles of miR-137 in post-transcriptional gene regulation in ASD. In a previously published study focusing on MIR137 gain-of-function mutations, Siegert et al. found that mRNAs and proteins of Cplx1, Nsf, Syn3, and Syt1 were consistently downregulated upon overexpression of miR-137 in vitro and in vivo 15 . In our RNA-seq and proteomics analyses, however, we did not observe substantial changes in these genes' expression levels, suggesting that the overexpression of miR-137 could target additional mRNAs compared to endogenous miRNA. Moreover, both our results and those of Siegert et al 15 . suggest that either miR-137 loss-of-function or gain-of-function could result in impaired learning and memory, indicating that miR-137-mediated regulation during neurodevelopment could be dosage-dependent.
Pde10a is one of the miR-137 mRNA targets that is linked to neuropsychiatric disorders 37 . Inhibition of Pde10a can ameliorate both dopaminergic and glutamatergic dysfunction, suggesting its attractive therapeutic potential in treating neuropsychiatric disorders 38 . Papaverine is a widely used selective inhibitor of Pde10a. Administration of papaverine produced increases in striatal tissue levels of cGMP and in extracellular cAMP. These effects of papaverine on biochemical and behavioral assays were absent in Pde10aknockout mice, indicating specific inhibitory effects of papaverine on Pde10a activity 41 . Given that Pde10a protein was elevated in heterozygous Mir137-knockout mice, we conducted several social deficit rescue experiments, and our results demonstrate that papaverine could indeed restore the impaired repetitive behaviors, sociability, and social novelty in Mir137 loxP/+ ;Nestin-Cre mice. Also, we found that papaverine could partially ameliorate learning and memory deficits, as well as repair neuronal morphological alterations associated with the partial loss of miR-137. These major rescue effects Mice. All mice used were from the 129S6/SvEvTac genetic background. We designed a targeting vector to disrupt the Mir137 gene via homologous recombination in mouse embryonic stem cells, where two loxP sites were inserted upstream (~2 kb) and downstream (~0.6 kb) of the Mir137 gene. By crossing with either Zp3-Cre or Nestin-Cre line, we were able to specifically delete Mir137 in the germline or central and peripheral nervous system and generate the heterozygous global knockout (gKO) and conditional knockout (cKO) mice. We then crossed heterozygous mice to generate miR-137 wild-type (Mir137 +/+ or Mir137 loxP/+ ), heterozygous (Mir137 +/or Mir137 loxP/+ ;Nestin-Cre), and homozygous (Mir137 -/or Mir137 loxP/loxP ;Nestin-Cre) mice. Genotyping was done using tail DNA, and the specific primers are shown in Supplementary Table 1 . Kaplan-Meier analysis was performed, and survival curves were generated using Prism 7 software (GraphPad).
Timed mating was performed by crossing heterozygous × heterozygous. The embryos were collected at embryonic day 15.5 (E15.5). Newborn mice were collected at postnatal day 0 (P0) for morphology analysis. Mice at P14 were used for histological analysis. Major organ tissues, such as heart, liver, lungs, and kidneys from miR-137 gKO mice were dissected immediately after the animals were killed for analysis, and fixed in 4% (mass/vol) paraformaldehyde (PFA) at 4 °C overnight, stored in 70% (vol/vol) ethanol, and embedded in paraffin. Paraffin blocks were sectioned at 5 μ m. After deparaffinization, the sections were stained with hematoxylin and eosin (H&E) using the standard procedure. H&E staining was performed on tissues from at least three mice per genotype.
Immunocytochemistry (ICC). ICC staining was performed as described previously 13 . In brief, cells were first preblocked using DPBS containing 5% normal goat serum (Vector Laboratories) and 0.1% Triton X-100 for 30 min, followed by overnight incubation with primary antibodies: mouse anti-microtubule-associated protein 2 (MAP2, 1:400; MAB3418; Millipore), mouse anti-postsynaptic density protein 95 (PSD-95; 1:500; ab2723; Abcam), or mouse anti-synaptophysin (1:300; ab8049; Abcam). After washing with DPBS, cells were incubated with secondary antibodies, goat anti-mouse Alexa Fluor 568 (1:500; A11031; Invitrogen) or goat anti-mouse Alexa Fluor 488 (1:500; A11001; Invitrogen), followed by counterstaining with DAPI (D9542; Sigma-Aldrich). Coverslips were then mounted on slides with Mowiol mounting medium.
Immunohistochemistry (IHC).
Four pairs of littermates of P18 cKO mice were anesthetized with 2.5% Avertin (200 mg/kg body weight) and transcardially perfused with cold PBS followed by 4% paraformaldehyde in phosphate buffer. The brains were removed and postfixed in 4% paraformaldehyde overnight, and then soaked overnight in 30% sucrose in PBS. Finally, the brains were sectioned into 40-μ m thickness using a Leica Sliding Microtome (SM2010 R). IHC staining of PSD-95 (1:500; ab2723; Abcam) and synaptophysin (1:300; ab8049; Abcam) was carried out on one in three 40-μ m-thick floating sections containing hippocampus and cortex from 4 pairs of littermates. IHC staining was also performed in P18 gKO Mir137 +/+ and Mir137 -/mice and in 8-week-old Mir137 +/+ and Mir137 +/mice.
Golgi staining. Golgi staining was performed as described previously 43 . In brief, brains from 4 pairs of independent littermate miR-137 cKO mice were harvested whole and rinsed with double distilled water. Brains were then incubated in a 1:1 mixture of FD Solution A:B (FD NeuroTechnologies) for 2 weeks at room temperature (22-25 °C) in the dark. Brains were then transferred into FD Solution C (FD NeuroTechnologies) and stored in the dark at room temperature for 48 h. Coronal sections (200 μ m) were cut with a Leica CM1950 cryostat and mounted on 3% gelatin-coated slides. Staining procedures were followed according to the manufacturer's protocol, and slides were dehydrated in ethanol and mounted with Permount medium. Dendrites were traced, and their lengths were measured using the Fiji plugin Simple Neurite Tracer. Spines were counted individually on secondary and tertiary branches of apical and basal dendrites in the CA1 hippocampal region.
Image analysis. Z-stack images (at 0.3 μ m intervals) were obtained on a ZEISS 710 confocal laser-scanning microscope with a 63 × oil-immersion lens at an electronic zoom factor of 1 or 2. Image analyses and quantification were performed using ImageJ software.
Behavioral assays. Mice were housed in groups of 3-5 animals on a 12:12-h light:dark cycle. For behavioral tests, mice were moved to the testing room 24 h before behavioral testing for acclimation. All experimental areas were cleaned with 70% ethanol before the tests and between subjects. All experiments occurred during the light phase. Data were collected blindly using the software Smart V3.0.03 (Panlab, Barcelona, Spain). Only 2-to 3-month-old male mice obtained from at least two independent cohorts were used for behavioral testing.
Morris water maze test. A circular water tank (diameter: 120 cm) was filled with water, and the water was made opaque with nontoxic white paint. A round platform (diameter: 13 cm) was hidden 1 cm beneath the surface of the water at the center of a given quadrant of the water tank. Mice received training in the Morris water maze for 4 successive days; each session consisted of 4 trials. For each trial, the mouse was released from the wall of the tank and allowed to search, find, and stand on the platform for 20 s within the 60-s trial period. For each training session, the starting quadrant and sequence of the four quadrants from which the mouse was released into the water tank were randomly chosen, such that it was different among the separate sessions for each animal and was different for individual animals. A probe test was conducted 24 h after completion of the training. During the probe test, the platform was removed from the pool, and task performance was recorded for 60 s. Mice in the water pool were recorded using a video camera, and task performance, including swimming tracks, speed, and time spent in each quadrant, were recorded for analysis.
Barnes Maze Task. The Barnes maze platform is circular, 122 cm in diameter, and has 20 evenly spaced holes (5 cm diameter, 2 cm away from the edge), with only one hole leading to a removable hiding box situated directly below the escape hole on the maze top. Testing begins on the first day by habituating the mice to the hiding box for 1 min. Following this, we performed 4 consecutive days of acquisition trials with 4 trials per day in which mice were allowed 5 min per trial to find the hiding box. Mice that did not find the hiding box by the end of the 5 min were gently guided to the escape hole by the investigator. Mice were returned to their home cage for 30 min between trials. A 60-s probe trial (no hiding box) was performed the day following the last day of acquisition. Animal movements in the maze were digitally recorded.
Self-grooming test. Mice were placed in a new Plexiglas cage with fresh bedding without nesting or cardboard material. Self-grooming behavior was recorded for 10 min. Cumulative time spent grooming and the number of grooming bouts were scored for each mouse.
Marble-burying task. Mice were individually placed in Plexiglas cages containing 5 cm-deep fresh bedding, followed by gently overlaying 20 black glass marbles (15 mm diameter) equidistant from each other in a 4 × 5 arrangement. Testing was conducted for 30 min. After the test period, unburied marbles were counted. Marbles were considered buried if they were at least half-covered with bedding.
Open-field test. The open field was made of plywood (painted white) 72 cm long × 72 cm wide × 36 cm tall. A central square (18 × 18 cm) was drawn in the middle of the open field and was used to measure exploration. Mice were placed in one corner of the open field apparatus and allowed explore the apparatus for 30 min while a video camera recorded their movements.
Social interaction test. Social interaction assay was performed as described previously 44 . Briefly, an adult Mir137 loxP/+ or Mir137 loxP/+ ;Nesting-Cre male mouse was placed with an unfamiliar juvenile male C57BL/6 J mouse in a clean, neutral Plexiglas cage (325 × 210 × 180 mm). We recorded 10-min sessions of social behaviors (nose-to-nose sniffing, nose-to-anogenital sniffing, self-grooming, following, crawling over or under the partner's body) of target mice and analyzed them; observers were blinded to genotypes.
Three-chamber social test. Sociability testing occurred in a rectangular, threechambered box as previously described 45 . Each chamber was 20 × 40 × 22 cm, and the dividing walls were made from clear Plexiglas, with small square openings (5 × 5 cm) allowing access into each chamber. The test animal was placed in the middle chamber and allowed to freely explore the test arena with an empty cage in each side chamber for the 10 min habituation period. Then, the mouse was led to the middle chamber, and the openings in the apparatus were closed. An unfamiliar C57BL/6 J male (Stranger 1) was then placed in a wire cage in one of the side chambers together with an empty wire cage in the other side chamber. The doors between chambers were then removed, and the test animal freely explored all three chambers over a 10-min session. Following this, a second novel stranger C57BL/6 J mouse (Stranger 2) was placed in the previously empty wire cage, and the subject mouse was allowed to explore again for 10 min. Animal movements were digitally recorded.
Social discrimination test. Two weeks before testing, subject animals and stimulus animals (female C57BL/6 mice aged 3-4 months) were housed alone in individual clean cages in the testing room. The social discrimination test was performed according to published protocols, with minor modifications 23, 24 . Testing took place in a novel, clean box (72 cm length × 72 cm width × 36 cm height) during the light phase. The subject mouse was habituated in the testing box for 5 min. After habituation, one stimulus female was introduced into one of two transparent bottles (9 cm in diameter, 12 cm high, with holes scattered over the surface allowing interaction), and interactions between the mice were videotaped for 5 min. The experimental animal was then returned to its home cage. 30 min later another unknown female was placed in the other bottle in the testing box; the experimental
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Software and code
Policy information about availability of computer code Data collection Z-stack images (at 0.3-μm intervals) were obtained on a ZEISS 710 confocal laser-scanning microscope with an X63 oil-immersion lens at an electronic zoom factor of 1 or 2. Image analyses and quantification were performed using ImageJ software. Behavioral assays: Data were collected blindly using the software Smart V3.0.03 (Panlab, Barcelona, Spain). Electrophysiology: The fEPSP signals were digitized using the Digidata 1440A interface board. Traces were obtained by pClamp 10.6 and analyzed using the Clampfit 10.6 (Axon Instruments, Foster City, CA).
Data analysis
Image analyses and quantification were performed using ImageJ software (1.49v). For RNAseq data, short read alignment, transcript expression estimation, and differential analysis were carried out using the Tophat2 (v2.1.1) and Cufflinks (v2.2.1) pipelines. The short reads were aligned against a reference gene database (Ensembl: Mus musculus, NCBIM37.62) without attempting to assemble novel transcripts. Proteomics data analysis was performed by our JUMP software (version 1.0.55) with improved sensitivity and specificity. Gene ontology (GO) analysis was performed by Database for Annotation, Visualization and Integrated Discovery (DAVID v6.8). The WEBbased GEne SeT AnaLysis Toolkit (WebGestalt) was used for additional GO analysis. GeneMANIA and Pathway Commons were used to predict the function and interaction of the differentially expressed genes. Predicted ASD-associated gene interaction networks were performed by genome-wide predictions of autism-associated genes (http://asd.princeton.edu/). Sylamer software (https:// www.ebi.ac.uk/research/enright/software/sylamer) was used to assess 3'UTR miRNA seed match enrichment p-values across the ranked protein list. A FASTA file containing 3'UTRs of protein-encoding genes was obtained and exported from Sylarray software (available at https://www.ebi.ac.uk/research/enright/software). All statistical analyses were performed using Prism 7.0 (GraphPad Software). Pearson's Chi-squared tests with Yates' continuity correction were performed in R software (http://www.rproject.org/). Conserved miR-137 predicted targets were obtained from TargetScanMouse Release 7.1 (http://www.targetscan.org/mmu_71/). Schizophrenia-
